Johnson Gyasi, Sallé Agnès, Lorimier Gérard, Laccourreye Laurent, Enon Bernard, Blin Vincent, Jousset Yann, Arnaud Jean-Pierre, Malthièry Yves, Simard Gilles, Ritz Patrick
Institut National de la Santé et de la Recherche Médicale, Unité 694, Université d'Angers; Laboratoire de biochimie et biologie moléculaire, Centre Hospitalier Universitaire, Angers, France.
Nutrition. 2008 May;24(5):443-50. doi: 10.1016/j.nut.2008.01.013. Epub 2008 Mar 24.
Cancer cachexia is associated with weight loss, poor nutritional status, and systemic inflammation. Accurate nutritional support for patients is calculated on resting energy expenditure (REE) measurement or prediction. The present study evaluated the agreement between measured and predicted REE (mREE and pREE, respectively) and the influence of acute phase response (APR) on REE.
Thirty-six patients with cancer were divided into weight-stable (WS; weight loss <2%) and weight-losing (WL; weight loss >5%) patients. Measured REE was measured by indirect calorimetry and adjusted for fat-free mass (FFM). The Bland-Altman approach was used to assess the agreement between mREE and pREE from the Harris-Benedict equations (HBE). Blood levels of C-reactive protein were assessed.
There was no difference in mREE between groups (WS 1677 +/- 273, WL 1521 +/- 305) even when mREE was adjusted for FFM (WS 1609 +/- 53, WL 1589 +/- 53). In WL patients, FFM-adjusted REE correlated with blood C-reactive protein levels (r = 0.471, P = 0.048). HBEs tend to underestimate REE in both groups.
WL and WS patients with cancer had similar REEs but were different in terms of APR. APR could contribute to weight loss through enhancing REE. In a clinical context, HBE was in poor agreement with mREE in both groups.
癌症恶病质与体重减轻、营养状况差和全身炎症相关。对患者进行准确的营养支持是根据静息能量消耗(REE)测量或预测来计算的。本研究评估了测量的REE与预测的REE(分别为mREE和pREE)之间的一致性以及急性期反应(APR)对REE的影响。
36例癌症患者被分为体重稳定组(WS;体重减轻<2%)和体重减轻组(WL;体重减轻>5%)。通过间接测热法测量测量的REE,并根据去脂体重(FFM)进行调整。采用Bland-Altman方法评估来自Harris-Benedict方程(HBE)的mREE和pREE之间的一致性。评估C反应蛋白的血药浓度。
两组之间的mREE没有差异(WS 1677±273,WL 1521±305),即使mREE根据FFM进行调整(WS 1609±53,WL 1589±53)。在WL患者中,经FFM调整的REE与血C反应蛋白水平相关(r = 0.471,P = 0.048)。HBEs在两组中都倾向于低估REE。
患有癌症的WL和WS患者具有相似的REE,但在APR方面有所不同。APR可能通过提高REE导致体重减轻。在临床情况下,两组中HBE与mREE的一致性都较差。